TAK1 activation of alpha-TAT1 and microtubule hyperacetylation control AKT signaling and cell growth
Name:
s41467-018-04121-y.pdf
Size:
4.884Mb
Format:
PDF
Description:
Final Published version
Author
Shah, NiravKumar, Sanjay
Zaman, Naveed
Pan, Christopher C.
Bloodworth, Jeffrey C.
Lei, Wei
Streicher, John M.
Hempel, Nadine
Mythreye, Karthikeyan
Lee, Nam Y.
Affiliation
Univ Arizona, Coll Med, Dept PharmacolUniv Arizona, Dept Chem & Biochem
Univ Arizona, Canc Ctr
Issue Date
2018-04-27
Metadata
Show full item recordPublisher
NATURE PUBLISHING GROUPCitation
Shah, N., Kumar, S., Zaman, N., Pan, C. C., Bloodworth, J. C., Lei, W., ... & Lee, N. Y. (2018). TAK1 activation of alpha-TAT1 and microtubule hyperacetylation control AKT signaling and cell growth. Nature communications, 9.Journal
NATURE COMMUNICATIONSRights
© The Author(s) 2018. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Acetylation of microtubules (MT) confers mechanical stability necessary for numerous functions including cell cycle and intracellular transport. Although alpha TAT1 is a major MT acetyltransferase, how this enzyme is regulated remains much less clear. Here we report TGF-beta-activated kinase 1 (TAK1) as a key activator of alpha TAT1. TAK1 directly interacts with and phosphorylates alpha TAT1 at Ser237 to critically enhance its catalytic activity, as mutating this site to alanine abrogates, whereas a phosphomimetic induces MT hyperacetylation across cell types. Using a custom phospho-alpha TAT1-Ser237 antibody, we screen various mouse tissues to discover that brain contains some of the highest TAK1-dependent alpha TAT1 activity, which, accordingly, is diminished rapidly upon intra-cerebral injection of a TAK1 inhibitor. Lastly, we show that TAK1 selectively inhibits AKT to suppress mitogenic and metabolism-related pathways through MT-based mechanisms in culture and in vivo. Collectively, our findings support a fundamental new role for TGF-beta signaling in MT-related functions and disease.ISSN
2041-1723PubMed ID
29703898Version
Final published versionSponsors
NIH [CA178443]; University of Arizona Cancer Center; University of Arizona Department of Pharmacology; University of Arizona Department of Chemistry and BiochemistryAdditional Links
http://www.nature.com/articles/s41467-018-04121-yae974a485f413a2113503eed53cd6c53
10.1038/s41467-018-04121-y
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s) 2018. This article is licensed under a Creative Commons Attribution 4.0 International License.
Related articles
- Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation.
- Authors: Ortiz HR, Cruz Flores P, Podgorski J, Ramonett A, Ahmed T, Hempel N, Charest PG, Ellis NA, Langlais PR, Montfort WR, Mythreye K, Kumar S, Lee NY
- Issue date: 2024 Jul
- αTAT1-induced tubulin acetylation promotes ameloblastoma migration and invasion.
- Authors: Yoshimoto S, Morita H, Okamura K, Hiraki A, Hashimoto S
- Issue date: 2022 Jan
- Regulation of FOXO1 by TAK1-Nemo-like kinase pathway.
- Authors: Kim S, Kim Y, Lee J, Chung J
- Issue date: 2010 Mar 12
- Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade.
- Authors: Choo MK, Kawasaki N, Singhirunnusorn P, Koizumi K, Sato S, Akira S, Saiki I, Sakurai H
- Issue date: 2006 Dec
- αTAT1 controls longitudinal spreading of acetylation marks from open microtubules extremities.
- Authors: Ly N, Elkhatib N, Bresteau E, Piétrement O, Khaled M, Magiera MM, Janke C, Le Cam E, Rutenberg AD, Montagnac G
- Issue date: 2016 Oct 18